ABLD yields 2.68% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ABLD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABLD + PFE for your $10,000?
ABLD invests primarily in US-listed companies of all market capitalization that are included in the real assets industry group. Sectors that comprise this group are as follows: real-estate related sectors, infrastructure-related sectors, commodities related sectors, and natural resources related sectors. Eligible securities are scored depending on their ability to generate profit and pay dividends using a fundamental evaluation that includes (1) quality of earnings (2) free cash flow profitability and (3) dividend yield. Those that represent the top 25% of the scored equity universe are considered for inclusion. Target weight is allocated to each security based on the combination of the three factors and market-cap. Based on the target weight, the index selects up to 75 stocks or until 90% of the cumulative security weight has been included, whichever occurs first. The fund may also invest in derivative instruments to maximize gains. The index is rebalanced and reconstituted quarterly. Prior to Nov. 13, 2024, the fund name was Donoghue Forlines Yield Enhanced Real Asset ETF and traded under the ticker DFRA.
Full ABLD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.